Your browser doesn't support javascript.
loading
Clinical conditions and risk factors for inhibitor-development in patients with haemophilia: A decade-long prospective cohort study in Japan, J-HIS2 (Japan Hemophilia Inhibitor Study 2).
Nogami, Keiji; Taki, Masashi; Matsushita, Tadashi; Kojima, Tetsuhito; Oka, Toshiaki; Ohga, Shouichi; Kawakami, Kiyoshi; Sakai, Michio; Suzuki, Takashi; Higasa, Satoshi; Horikoshi, Yasuo; Shinozawa, Keiko; Tamura, Shogo; Yada, Koji; Imaizumi, Masue; Ohtsuka, Yoshitoshi; Iwasaki, Fuminori; Kobayashi, Masao; Takamatsu, Junki; Takedani, Hideyuki; Nakadate, Hisaya; Matsuo, Yoko; Matsumoto, Takeshi; Fujii, Teruhisa; Fukutake, Katsuyuki; Shirahata, Akira; Yoshioka, Akira; Shima, Midori.
  • Nogami K; Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan.
  • Taki M; Department of Pediatrics, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
  • Matsushita T; Department of Transfusion Medicine, Nagoya University Hospital, Nagoya, Japan.
  • Kojima T; Aichi Health Promotion Foundation, Nagoya, Aichi, Japan.
  • Oka T; Nagoya University, Nagoya, Aichi, Japan.
  • Ohga S; Department of Pediatrics, Sapporo Tokushukai Hospital, Sapporo, Japan.
  • Kawakami K; Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Sakai M; Department of Pediatrics, Kagoshima City Hospital, Kagoshima, Japan.
  • Suzuki T; Department of Pediatrics, University of Occupational and Environmental Health Japan, Kitakyushu, Japan.
  • Higasa S; Department of Pediatrics, Munakata Suikokai General Hospital, Fukuoka, Japan.
  • Horikoshi Y; Department of Blood Coagulation, Ogikubo Hospital, Tokyo, Japan.
  • Shinozawa K; Department of Hematology, Hyogo College of Medicine, Nishinomiya, Japan.
  • Tamura S; Division of Hematology and Oncology, Shizuoka Children's Hospital, Shizuoka, Japan.
  • Yada K; Department of Laboratory Medicine, Tokyo Medical University, Tokyo, Japan.
  • Imaizumi M; Division of Cellular and Genetic Sciences, Department of Integrated Health Sciences, Nagoya University Graduate School of medicine, Nagoya, Japan.
  • Ohtsuka Y; Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan.
  • Iwasaki F; Division of Hemophilia, National Hospital Organization Osaka National Hospital, Osaka, Japan.
  • Kobayashi M; Department of Hematology and Oncology, Miyagi Children's Hospital, Sendai, Japan.
  • Takamatsu J; Department of Pediatrics, Hyogo College of Medicine, Nishinomiya, Japan.
  • Takedani H; Division of Hematology and Oncology, Kanagawa Children's Medical Center, Yokohama, Japan.
  • Nakadate H; Department of Pediatrics, Hiroshima University Hospital, Hiroshima, Japan.
  • Matsuo Y; Department of Transfusion Medicine, Nagoya University Hospital, Nagoya, Japan.
  • Matsumoto T; Japanese Red Cross Tokai Hokuriku Block Blood Center, Seto, Japan.
  • Fujii T; Department of Joint Surgery, IMSUT hospital, The University of Tokyo, Tokyo, Japan.
  • Fukutake K; Division of Hematology, Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.
  • Shirahata A; Department of Pediatrics and Child Health, Kurume University School of Medicine, Kurume, Japan.
  • Yoshioka A; Department of Transfusion Medicine and Cell Therapy, Mie University Hospital, Tsu, Japan.
  • Shima M; Division of Transfusion Medicine, Hiroshima University Hospital, Hiroshima, Japan.
Haemophilia ; 28(5): 745-759, 2022 Sep.
Article en En | MEDLINE | ID: mdl-35689832

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hemofilia A Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País como asunto: Asia Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hemofilia A Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País como asunto: Asia Idioma: En Año: 2022 Tipo del documento: Article